# STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)

> **NCT07278310** · NA · RECRUITING · sponsor: **MiRus** · enrollment: 1025 (estimated)

## Conditions studied

- Symptomatic Severe Native Aortic Stenosis
- Aortic Stenosis

## Interventions

- **DEVICE:** TAVR Device
- **DEVICE:** Siegel TAVR Device

## Key facts

- **NCT ID:** NCT07278310
- **Lead sponsor:** MiRus
- **Sponsor class:** INDUSTRY
- **Phase:** NA
- **Study type:** INTERVENTIONAL
- **Status:** RECRUITING
- **Start date:** 2026-04
- **Primary completion:** 2028-04
- **Final completion:** 2028-04
- **Target enrollment:** 1025 (ESTIMATED)
- **Last updated:** 2026-04-09


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT07278310

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT07278310, "STAR Trial (Siegel Transcatheter Aortic Valve Replacement in Patients With Symptomatic Severe Aortic Stenosis)". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT07278310. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*